NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/20/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.27 mln
Float1.17 mln
Earnings Date05/15/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
27.00
Transformational upside
Relative Strength
95
/ 100
Top performer
Debt / Equity
0.22
Very low leverage
ROE
-428
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
ENDRA Life Sciences Inc. is a Michigan-based medical technology company founded in 2007. It has developed a specialized imaging system that combines radio frequency energy with ultrasound to produce clearer, more detailed pictures of tissue inside the body. This technology is primarily aimed at helping doctors better detect and manage conditions such as fatty liver disease, while also supporting applications in blood flow monitoring and tissue analysis.
